ASSET PURCHASE AGREEMENT Among EirGen Pharma Limited, Horizon Therapeutics Ireland DAC And OPKO Health, Inc. (solely for the purposes of Sections 2.1, 8.3 and 11.16) Dated as of June 16, 2021Asset Purchase Agreement • July 29th, 2021 • Opko Health, Inc. • Pharmaceutical preparations
Contract Type FiledJuly 29th, 2021 Company IndustryThis Asset Purchase Agreement is dated as of June 16, 2021, among OPKO Health, Inc., a Delaware corporation (“Parent”) (solely for the purposes Sections 2.1, 8.3 and 11.16) and EirGen Pharma Limited, a private limited company incorporated under the laws of Ireland registered with the Irish Companies Office under company number 398605 (“Seller”), and Horizon Therapeutics Ireland DAC, a designated activity company incorporated under the laws of Ireland registered with the Irish Companies Office under company number 376554 (“Purchaser”) (each, a “Party” and collectively, the “Parties”). Capitalized terms used in this Agreement shall have the meanings indicated in Section 1.1.
ASSET PURCHASE AGREEMENT between ARLO TECHNOLOGIES, INC. and VERISURE S.À.R.L. Dated as of November 4, 2019Asset Purchase Agreement • February 28th, 2020 • Arlo Technologies, Inc. • Household audio & video equipment • Delaware
Contract Type FiledFebruary 28th, 2020 Company Industry JurisdictionThis ASSET PURCHASE AGREEMENT is dated as of November 4, 2019 (the “Agreement”), between Arlo Technologies, Inc., a Delaware corporation (“Seller”), and Verisure S.À.R.L., a Swiss limited liability company (“Purchaser”) (each, a “Party” and collectively, the “Parties”). Capitalized terms used in this Agreement shall have the meanings indicated in Section 1.1.